NYSE | ETF
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective.
The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS).
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| APLS | Apellis Pharmaceuticals Inc | Healthcare | Biotechnology | 1.43% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.41% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 1.29% |
| TGTX | TG Therapeutics Inc | Healthcare | Biotechnology | 1.26% |
| TVTX | Travere Therapeutics Inc | Healthcare | Biotechnology | 1.22% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.19% |
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 1.16% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 1.10% |
| ERAS | Erasca Inc | Healthcare | Biotechnology | 0.98% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 0.94% |
| ARWR | Arrowhead Pharmaceuticals Inc | Healthcare | Biotechnology | 0.94% |
| ALPN | Alpine Immune Sciences Inc | Healthcare | Biotechnology | 0.94% |
| RARE | Ultragenyx | Healthcare | Biotechnology | 0.94% |
| KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 0.93% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 0.93% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 0.92% |
| SLNO | Soleno Therapeutics Inc | Healthcare | Biotechnology | 0.91% |
| MTSR | Metsera, Inc. Common Stock | Healthcare | Biotechnology | 0.91% |
| NUVL | Nuvalent Inc | Healthcare | Biotechnology | 0.91% |
| CELC | Celcuity LLC | Healthcare | Biotechnology | 0.90% |